Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$306.88 - $380.0 $12,888 - $15,960
42 Added 3.17%
1,366 $516,000
Q3 2023

Nov 13, 2023

BUY
$315.92 - $397.36 $67,922 - $85,432
215 Added 19.39%
1,324 $421,000
Q2 2023

Aug 14, 2023

SELL
$346.15 - $392.09 $156,459 - $177,224
-452 Reduced 28.96%
1,109 $425,000
Q1 2023

May 15, 2023

SELL
$323.56 - $373.36 $42,709 - $49,283
-132 Reduced 7.8%
1,561 $582,000
Q4 2022

Feb 14, 2023

BUY
$248.67 - $334.17 $14,671 - $19,716
59 Added 3.61%
1,693 $559,000
Q3 2022

Oct 24, 2022

BUY
$263.81 - $337.27 $2,374 - $3,035
9 Added 0.55%
1,634 $431,000
Q2 2022

Aug 08, 2022

SELL
$301.4 - $428.42 $201,335 - $286,184
-668 Reduced 29.13%
1,625 $508,000
Q1 2022

May 16, 2022

SELL
$379.46 - $424.54 $223,122 - $249,629
-588 Reduced 20.41%
2,293 $958,000
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $11,205 - $13,023
-30 Reduced 1.03%
2,881 $1.21 Million
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $623,706 - $716,706
1,572 Added 117.4%
2,911 $1.2 Million
Q2 2021

Aug 12, 2021

SELL
$372.36 - $412.07 $20,852 - $23,075
-56 Reduced 4.01%
1,339 $531,000
Q1 2021

May 14, 2021

BUY
$357.26 - $392.57 $168,626 - $185,293
472 Added 51.14%
1,395 $536,000
Q4 2020

Feb 11, 2021

BUY
$319.05 - $363.32 $294,483 - $335,344
923 New
923 $335,000
Q4 2019

Jan 24, 2020

SELL
$281.18 - $322.05 $268,245 - $307,235
-954 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$294.25 - $341.49 $280,714 - $325,781
954 New
954 $283,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.